Related Experiment Videos

Rheosmin, a naturally occurring phenolic compound inhibits LPS-induced iNOS and COX-2 expression in RAW264.7 cells by

Jin Boo Jeong1, Hyung Jin Jeong

  • 1Bioresource Sciences, Andong National University, Andong 760749, Republic of Korea.

Insights

Rheosmin, a compound from pine needles, effectively reduces inflammation markers like nitric oxide and prostaglandin E2. It inhibits key inflammatory pathways, suggesting potential therapeutic benefits for chronic inflammatory diseases.

Area of Science:

  • Natural Product Chemistry
  • Immunology
  • Molecular Biology

Background:

  • Inflammation is a critical defense mechanism but aberrant inflammation contributes to chronic diseases like cancer.
  • Raspberry ketone is a known phenolic compound used in various industries.
  • Understanding natural compounds' anti-inflammatory properties is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of rheosmin, a phenolic compound from pine needles.
  • To determine rheosmin's impact on inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression.
  • To elucidate the molecular mechanisms underlying rheosmin's anti-inflammatory action in lipopolysaccharide (LPS)-stimulated cells.

Main Methods:

  • Utilized RAW264.7 macrophage cell line stimulated with LPS.
  • Quantified nitric oxide (NO) and prostaglandin E2 (PGE2) production.
  • Assessed iNOS and COX-2 protein expression.
  • Investigated the nuclear translocation of NF-kappaB p65 and IkappaB degradation/phosphorylation.

Main Results:

  • Rheosmin demonstrated dose-dependent inhibition of NO and PGE2 production.
  • Rheosmin significantly blocked LPS-induced iNOS and COX-2 protein expression.
  • Rheosmin inhibited the nuclear translocation of NF-kappaB p65 by preventing IkappaB degradation and phosphorylation, indicating NF-kappaB pathway inhibition.

Conclusions:

  • Rheosmin exhibits potent anti-inflammatory properties in LPS-stimulated RAW264.7 cells.
  • The mechanism involves the inhibition of NF-kappaB activation pathway.
  • Rheosmin's ability to suppress iNOS and COX-2 expression suggests its potential as a therapeutic agent for inflammatory conditions.